Table 2: Analysis of association of polymorphisms in patients with and without metabolic syndrome* (n = 72). Extended Western Region of Minas Gerais, MG, Brazil, 2015.

Polymorphism	Without MS*		With MS*		p†
	N	%	N	%
TaqIA genotypes
Homozygous for the C allele	21	55.3	16	47.1	0.708
Heterozygous	15	39.5	15	44.1
Homozygous for the T allele	2	5.3	3	8.8
TaqIA alleles
C	36	67.9	31	63.3	0.620
T	17	32.1	18	36.7
-141C genotypes
Homozygous for the Del C allele	25	65.8	24	70.6	0.184
Heterozygous	12	31.6	6	17.6
Homozygous for the Ins C allele	1	2.6	4	11.8
-141C alleles
Del C	37	74.0	30	75.0	0.914
Ins C	13	26.0	10	25.0
rs6280 genotypes
Homozygous for the T allele	16	42.1	9	26.5	0.311
Heterozygous	13	34.2	17	50.0
Homozygous for the C allele	9	23.7	8	23.5
rs6280 alleles
C	45	40.8	25	41.7	0.551
T	29	59.2	35	58.3

*Metabolic Syndrome †χ² Test; level of significance: p < 0.05.